The Ukrainian Ministry of Health registered the Korean-made AstraZeneca-SKBio vaccine against COVID-19 for emergency medical use on April 20, the ministry said on Facebook on Wednesday. According to the report, AstraZeneca-SKBio is developed by the University of Oxford and the British-Swedish company AstraZeneca.